Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Health

Oxford Nanopore sets IPO plans in motion

Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.


Sep 21, 2021

Daily Deal Round Up: September 20, 2021

Ideo contributed to female-focused debit card provider Sequin's $5m seed round while Nikon has exited motion data software developer Wrnch.

Sep 20, 2021

Daily deal net: September 20, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 20, 2021

Caresyntax tracks up series C to $130m

ProAssurances and Reylens Group helped the surgical software provider add $30m to a series C round now totalling $130m.

Sep 20, 2021

DeltaHealth raises pulse to $100m

Swire Pacific led a funding round for the cardiovascular healthcare provider as it prepares to expand its network of facilities in China.

Sep 20, 2021

Wrnch pulls off acquisition

Hinge Health has bought Wrnch, a computer vision technology developer exploiting research from Concordia University.

Sep 20, 2021

Anjarium apprehends $60m in series A funding

Pfizer Ventures participated in a series A round for genetic therapeutics developer Anjarium Biosciences that was co-led by Abingworth and Gimv.

Sep 20, 2021

Analysis: Prenetics in a $1.25bn reverse merger

Alibaba and Ping An-backed Prenetics is set to complete a reverse merger at a $1.25bn valuation. Exits from the broader genetics and gene therapeutics space appear to be in the middle of a valuation spike, according to our data.

Sep 20, 2021

Daily Deal Round Up: September 17, 2021

Conductive Ventures returned for online savings platform developer Self Financial's $50m series E round while EV producer Volta Trucks completed its $43.6m series B.

Sep 17, 2021

Spring Health secures $190m

Digital mental health platform Spring Health was valued at $2bn through a series C round backed by strategic investor Guardian Life.

Sep 17, 2021

Amolyt shows ambition with $80m series B

The endocrine disease treatment developer pushed its overall funding past $160m in a round featuring Novo, Sham and Mass General Brigham.

Sep 17, 2021

Prenetics tests out $1.25bn reverse merger

Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.

Sep 17, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here